Detailed information for compound 500023

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 555.548 | Formula: C28H28F3N5O4
  • H donors: 2 H acceptors: 5 LogP: 4.31 Rotable bonds: 11
    Rule of 5 violations (Lipinski): 2
  • SMILES: O=C([C@@H](Cc1ccccc1OC(F)(F)F)NC(=O)c1cncnc1)N[C@@H]1CCc2c(N(C1=O)C(C)C)cccc2
  • InChi: 1S/C28H28F3N5O4/c1-17(2)36-23-9-5-3-7-18(23)11-12-21(27(36)39)34-26(38)22(35-25(37)20-14-32-16-33-15-20)13-19-8-4-6-10-24(19)40-28(29,30)31/h3-10,14-17,21-22H,11-13H2,1-2H3,(H,34,38)(H,35,37)/t21-,22-/m1/s1
  • InChiKey: AOWGWPRODWVCGS-FGZHOGPDSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens sodium channel, voltage-gated, type IX, alpha subunit Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Echinococcus granulosus sodium channel protein Get druggable targets OG5_126819 All targets in OG5_126819
Leishmania infantum calcium channel protein, putative,ion transporter, putative Get druggable targets OG5_126819 All targets in OG5_126819
Echinococcus multilocularis sodium channel protein Get druggable targets OG5_126819 All targets in OG5_126819
Echinococcus granulosus voltage gated sodium channel Nav1 alpha subunit Get druggable targets OG5_126819 All targets in OG5_126819
Leishmania major calcium channel protein, putative,ion transporter, putative Get druggable targets OG5_126819 All targets in OG5_126819
Leishmania donovani calcium channel protein, putative Get druggable targets OG5_126819 All targets in OG5_126819
Leishmania mexicana calcium channel protein, putative,ion transporter, putative Get druggable targets OG5_126819 All targets in OG5_126819
Leishmania braziliensis calcium channel protein, putative,ion transporter, putative Get druggable targets OG5_126819 All targets in OG5_126819

By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Mycobacterium leprae PROBABLE OXIDOREDUCTASE 0.0032 0.4802 1
Brugia malayi oxidoreductase, aldo/keto reductase family protein 0.0032 0.4802 0.7688
Leishmania major DNA polymerase kappa, putative 0.0025 0.2481 0.2773
Mycobacterium ulcerans DNA polymerase IV 0.0049 1 1
Trypanosoma brucei DNA polymerase kappa, putative 0.0037 0.6246 0.6246
Echinococcus granulosus aldo keto reductase family 1 member B4 0.0032 0.4802 0.4802
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.0032 0.4802 0.4802
Schistosoma mansoni aldo-keto reductase 0.0032 0.4802 1
Echinococcus granulosus hypothetical protein 0.0032 0.4802 0.4802
Trypanosoma brucei DNA polymerase kappa, putative 0.0049 1 1
Echinococcus granulosus aldo keto reductase 0.0032 0.4802 0.4802
Onchocerca volvulus 0.0032 0.4802 0.5
Echinococcus multilocularis aldo keto reductase 0.0032 0.4802 0.4802
Trypanosoma brucei DNA polymerase kappa, putative 0.0049 1 1
Giardia lamblia Aldose reductase 0.0032 0.4802 1
Trypanosoma brucei DNA polymerase kappa, putative 0.0037 0.6246 0.6246
Echinococcus granulosus aldo keto reductase 0.0032 0.4802 0.4802
Trypanosoma cruzi DNA polymerase kappa, putative 0.0049 1 1
Loa Loa (eye worm) oxidoreductase 0.0032 0.4802 0.7688
Brugia malayi oxidoreductase, aldo/keto reductase family protein 0.0032 0.4802 0.7688
Trypanosoma brucei unspecified product 0.0041 0.7519 0.7519
Trypanosoma brucei DNA polymerase kappa, putative 0.002 0.0792 0.0792
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.0032 0.4802 0.4802
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.0032 0.4802 0.4802
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.0032 0.4802 0.4802
Trypanosoma brucei DNA polymerase kappa, putative 0.0049 1 1
Onchocerca volvulus 0.0032 0.4802 0.5
Loa Loa (eye worm) oxidoreductase 0.0032 0.4802 0.7688
Leishmania major DNA polymerase kappa, putative,DNA polymerase IV, putative 0.0025 0.2481 0.2773
Echinococcus granulosus aldo keto reductase family 1 member B4 0.0032 0.4802 0.4802
Echinococcus granulosus aldo keto reductase family 1 member B4 0.0032 0.4802 0.4802
Echinococcus granulosus aldo keto reductase family 1 member B4 0.0032 0.4802 0.4802
Loa Loa (eye worm) oxidoreductase 0.0032 0.4802 0.7688
Echinococcus multilocularis dna polymerase kappa 0.0049 1 1
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.0032 0.4802 0.4802
Echinococcus granulosus aldo keto reductase family 1 member B4 0.0032 0.4802 0.4802
Trypanosoma cruzi DNA polymerase kappa, putative 0.0049 1 1
Trypanosoma brucei DNA polymerase IV, putative 0.0049 1 1
Leishmania major aldo-keto reductase-like protein 0.0032 0.4802 0.5367
Loa Loa (eye worm) hypothetical protein 0.0037 0.6246 1
Loa Loa (eye worm) oxidoreductase 0.0032 0.4802 0.7688
Loa Loa (eye worm) oxidoreductase 0.0032 0.4802 0.7688
Mycobacterium tuberculosis Probable oxidoreductase 0.0032 0.4802 1
Echinococcus granulosus aldehyde reductase 0.0023 0.1835 0.1835
Toxoplasma gondii aldose reductase, putative 0.0032 0.4802 0.5
Onchocerca volvulus 0.0032 0.4802 0.5
Trypanosoma cruzi aldo/keto reductase, putative 0.0032 0.4802 0.4802
Brugia malayi polk-prov protein 0.0037 0.6246 1
Trypanosoma brucei DNA polymerase kappa, putative 0.0049 1 1
Trypanosoma brucei DNA polymerase kappa, putative 0.002 0.0792 0.0792
Echinococcus multilocularis aldo keto reductase 0.0032 0.4802 0.4802
Brugia malayi oxidoreductase, aldo/keto reductase family protein 0.0032 0.4802 0.7688
Echinococcus granulosus aldo keto reductase family 1 member B4 0.0032 0.4802 0.4802
Entamoeba histolytica aldose reductase, putative 0.0032 0.4802 1
Trypanosoma brucei aldo-keto reductase, putative 0.0032 0.4802 0.4802
Trypanosoma brucei DNA polymerase kappa, putative 0.0049 1 1
Echinococcus granulosus aldo keto reductase family 1 member B4 0.0032 0.4802 0.4802
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.0032 0.4802 0.4802
Echinococcus granulosus voltage gated sodium channel Nav1 alpha subunit 0.0045 0.8947 0.8947
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.0032 0.4802 0.4802
Mycobacterium tuberculosis Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) 0.0025 0.2481 0.5166
Echinococcus multilocularis aldo keto reductase 0.0032 0.4802 0.4802
Entamoeba histolytica aldose reductase, putative 0.0032 0.4802 1
Leishmania major aldehyde reductase, putative,oxidoreductase, putative 0.0032 0.4802 0.5367
Schistosoma mansoni pol-related 0.0032 0.4802 1
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.0032 0.4802 0.4802
Mycobacterium ulcerans DNA polymerase IV 0.0049 1 1
Echinococcus multilocularis aldehyde reductase 0.0023 0.1835 0.1835
Trichomonas vaginalis DNA polymerase eta, putative 0.0049 1 1
Trypanosoma brucei DNA polymerase IV, putative 0.0049 1 1
Onchocerca volvulus 0.0032 0.4802 0.5
Trypanosoma brucei DNA polymerase kappa, putative 0.0025 0.2481 0.2481
Echinococcus granulosus aldo keto reductase family 1 member B4 0.0032 0.4802 0.4802
Brugia malayi oxidoreductase, aldo/keto reductase family protein 0.0032 0.4802 0.7688
Trichomonas vaginalis DNA polymerase IV / kappa, putative 0.0049 1 1
Trypanosoma cruzi aldo-keto reductase 0.0032 0.4802 0.4802
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.0032 0.4802 0.4802
Loa Loa (eye worm) hypothetical protein 0.0032 0.4802 0.7688
Echinococcus granulosus aldo keto reductase 0.0032 0.4802 0.4802
Leishmania major prostaglandin f synthase, putative 0.0032 0.4802 0.5367
Leishmania major calcium channel protein, putative,ion transporter, putative 0.0045 0.8947 1
Trypanosoma cruzi DNA polymerase kappa, putative 0.0049 1 1
Giardia lamblia Aldose reductase 0.0032 0.4802 1
Echinococcus granulosus sodium channel protein 0.0045 0.8947 0.8947
Entamoeba histolytica aldose reductase, putative 0.0032 0.4802 1
Trypanosoma brucei prostaglandin f synthase 0.0032 0.4802 0.4802
Onchocerca volvulus 0.0032 0.4802 0.5
Leishmania major prostaglandin f2-alpha synthase/D-arabinose dehydrogenase 0.0032 0.4802 0.5367
Trypanosoma brucei DNA polymerase kappa, putative 0.002 0.0792 0.0792
Echinococcus multilocularis aldo keto reductase 0.0032 0.4802 0.4802
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.0032 0.4802 0.4802
Trypanosoma brucei DNA polymerase kappa, putative 0.0049 1 1
Echinococcus granulosus aldo keto reductase family 1 member B4 0.0032 0.4802 0.4802
Onchocerca volvulus 0.0032 0.4802 0.5
Trypanosoma brucei DNA polymerase kappa, putative 0.0049 1 1
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.0032 0.4802 0.4802
Schistosoma mansoni aldo-keto reductase 0.0032 0.4802 1
Trypanosoma brucei DNA polymerase kappa, putative 0.0049 1 1
Trypanosoma brucei DNA polymerase kappa, putative 0.0049 1 1
Echinococcus multilocularis sodium channel protein 0.0045 0.8947 0.8947
Trypanosoma cruzi DNA polymerase kappa, putative 0.0049 1 1
Trypanosoma brucei DNA polymerase IV, putative 0.0041 0.7519 0.7519

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) > 1000 nM Inhibition of human sodium channel Nav1.7 by FRET assay ChEMBL. 17889534
IC50 (binding) > 1000 nM Inhibition of human sodium channel Nav1.7 by FRET assay ChEMBL. 17889534

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

No external resources registered for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.